By 4 weeks, GLP-1 receptor mRNA returned to normal levels while the stomach slowing effect disappeared [24]
For instance, on January 2, 2026, Eli Lilly announced that its self-developed GIP/GLP-1 receptor dual agonist tirzepatide injection, Mounjaro, was officially launched in China
[4] Crucially for weight management, these drugs act on receptors in the brainparticularly in the hypothalamus and brainstemto reduce appetite and increase feelings of satiety
Daily use offers a gentle, brightening effect for both face and body
Add less water and the solution is more concentrated, which suits larger doses
Skin Lightening Bespoke treatments that are individualised for YOUR skin type gives the best results